Financial Comparison of Glaxo Smith Kline and Cheniere Energy

1702 Words4 Pages

Financial Comparison of Glaxo Smith Kline and Cheniere Energy

The companies that I have been assigned to analyze and compare are Glaxo Smith Kline (GSK) of the UK, the second largest pharmaceutical company in the world, and Cheniere Energy (LNG), a small struggling Downstream Oil company that operates out of Houston, Tx. To attain the financial information, such as a 10 K filing, income statements, balance sheets, statements of cash flow, and background information on each company, I used a combination of the SECs’ Edgar, Mergent online, Google finance, and Reuters online. I will also refer to each companies corporate websites to complete my research, these are noted in the footnotes as well as the websites mention earlier. In my research I will identify the conservative accounting choices of both companies and make comparisons on my findings. My first impression of this analization is that I am comparing two companies that that are very unalike. The different attributes of these companies that I can see initially are the industry, size of company, and the geographical location of operations.

Cheniere Energy, Inc., through its subsidiaries, is engaged primarily in the business of developing and constructing, and then owning and operating, a network of three onshore liquefied natural gas receiving terminals and natural gas pipelines. The Company is developing a business to market liquid natural gas and natural gas primarily through its wholly owned subsidiary, Cheniere Marketing. To a limited extent, Cheniere is also engaged in oil and natural gas exploration and development activities in the Gulf of Mexico. The Company has four business segments: liquid natural gas receiving terminal business, natural gas pipeline business, liquid natural gas and natural gas marketing business, and oil and gas exploration and development business.

GlaxoSmithKline is a United Kingdom-based pharmaceutical, biological, and healthcare company. GSK is the world's second largest pharmaceutical company and a research-based company with a wide portfolio of pharmaceutical products covering anti-infectives, central nervous system, respiratory, gastro-intestinal/metabolic, oncology, and vaccines products. It also has a Consumer Healthcare operation comprising leading oral healthcare products, nutritional drinks, and over the counter medicines.

In recent years GSK has thrived in the worldwide pharmaceutical market. Cheniere has had trouble staying afloat. Before hurricane Katrina Cheniere made risky organizational decisions to further the success of the business. Cheniere decided to build liquid natural gas receiving terminals to further the flow into the pipelines. The decision makers at Cheniere had no way of knowing that the completion of these receiving terminals would be cut short by Hurricane Katrina.

More about Financial Comparison of Glaxo Smith Kline and Cheniere Energy

Open Document